Case Report: Ocular toxoplasmosis in a WHIM syndrome immunodeficiency patient.

CXCR4 Genetic Immunodeficiency Optic neuritis Retinitis Toxoplasma gondii Treatment

Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
Historique:
accepted: 01 11 2018
entrez: 29 6 2019
pubmed: 30 6 2019
medline: 30 6 2019
Statut: epublish

Résumé

A patient with WHIM syndrome immunodeficiency presented with sudden painless right eye blindness associated with advanced retinal and optic nerve damage.

Identifiants

pubmed: 31249677
doi: 10.12688/f1000research.16825.1
pmc: PMC6587139
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

2

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

Ophthalmology. 2002 May;109(5):869-78
pubmed: 11986090
Neurology. 2004 Dec 14;63(11):2192-3
pubmed: 15596786
Eye (Lond). 2007 Jun;21(6):746-51
pubmed: 16575416
J Clin Pathol. 2008 Nov;61(11):1220-2
pubmed: 18955577
Blood. 2010 Dec 2;116(23):4870-3
pubmed: 20736454
J Pediatr. 2012 Oct;161(4):763-5
pubmed: 22748845
Semin Immunopathol. 2012 Nov;34(6):793-813
pubmed: 22955326
Parasite. 2013;20:18
pubmed: 23688778
Blood. 2013 Aug 1;122(5):666-73
pubmed: 23794067
Prog Retin Eye Res. 2014 Mar;39:77-106
pubmed: 24412517
Am J Trop Med Hyg. 2014 May;90(5):794-799
pubmed: 24808246
J AAPOS. 2016 Feb;20(1):85-8
pubmed: 26917084
PLoS Negl Trop Dis. 2016 Apr 25;10(4):e0004605
pubmed: 27111140
Eye Brain. 2015 Sep 28;7:59-81
pubmed: 28539795
Expert Opin Orphan Drugs. 2017;5(10):813-825
pubmed: 29057173
Medicine (Baltimore). 2017 Dec;96(49):e8989
pubmed: 29245273
Korean J Parasitol. 2018 Apr;56(2):147-152
pubmed: 29742869
Mediators Inflamm. 2019 Feb 17;2019:9356728
pubmed: 30906227
J Exp Med. 2019 Jun 12;:null
pubmed: 31189656
Am J Med Sci. 1984 May-Jun;287(3):36-8
pubmed: 6731479
Clin Infect Dis. 1997 Apr;24(4):745-6
pubmed: 9145762
J Pediatr. 1997 Jul;131(1 Pt 1):47-54
pubmed: 9255191
J Clin Immunol. 1998 Jul;18(4):283-90
pubmed: 9710745
Eur J Pediatr. 1998 Sep;157(9):735-7
pubmed: 9776532

Auteurs

David H McDermott (DH)

Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Lauren E Heusinkveld (LE)

Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Wadih M Zein (WM)

National Eye Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA.

H Nida Sen (HN)

National Eye Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Martha M Marquesen (MM)

Laboratory of Clinical Immunology and Microbiology, National Institute Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Mark Parta (M)

Clinical Research Directorate/Clinical Monitoring Research Program, Bethesda, MD, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Bethesda, Maryland, 20892, USA.

Sergio D Rosenzweig (SD)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Gary A Fahle (GA)

Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Michael D Keller (MD)

Division of Allergy & Immunology, Children's National Medical Center, Washington, DC, 20010, USA.

Henry E Wiley (HE)

National Eye Institute, National Institutes of Health, Bethesda, Maryland, 20892, USA.

Philip M Murphy (PM)

Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

Classifications MeSH